▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2400 by analyst upside · 2026-08-13
XRAY
DENTSPLY SIRONA Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+19.1%
implied upside to consensus target
Current Price $11.41
Consensus Target $13.59
Bull Target $17.0
Bear Target $9.0
Analysts Covering 16
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
2
Hold
12
Sell
1
52-Week Low $9.41
52-Week High $14.86
YTD Return +1.2%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 7.5x
EPS (TTM) $-2.73
PEG Ratio 0.75
Dividend Yield 5.04%
Revenue (TTM) $3.6B
Profit Margin -15.0%
52-WEEK RANGE
52-Week Low $9.41
52-Week High $14.86
Current Price $11.41
Bear Target $9.0
Bull Target $17.0
● Now $11.41 ● Target $13.59
TRADING DATA
Avg Volume 5.8M
YTD Return +1.2%
Analyst Count 16
Consensus Hold
Upside to Target +19.1%
Last Updated 2026-08-13

ANALYST SUMMARY

DENTSPLY SIRONA Inc. (XRAY) is currently trading at $11.41 with a Wall Street consensus price target of $13.59, implying potential upside of 19.1% over the next 12 months. 16 analysts currently cover XRAY, with a consensus rating of Hold - 19% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $17.0, while the most cautious has a target of $9.0.

XRAY operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 1.2% year-to-date and is currently trading near the lower end of its 52-week range of $9.41 – $14.86.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

MD -1.3%
Pediatrix Medical Group, Inc.
$2B · P/E 12.7x · Hold
ADUS +14.1%
Addus HomeCare Corporation
$2B · P/E 20.5x · Buy
TMDX +11.8%
TransMedics Group, Inc.
$3B · P/E 23.1x · Buy
HCSG +28.8%
Healthcare Services Group, Inc.
$1B · P/E 12.2x · Hold
OPCH +19.9%
Option Care Health, Inc.
$4B · P/E 18.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for XRAY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Underweight → Underweight 2026-06-04 Building track record
UBS - Reiterated
Buy → Buy 2026-05-07 33% win rate (6 calls)
Mizuho - Reiterated
Neutral → Neutral 2026-05-06 Building track record
Citigroup ● Initiated
Sell 2026-04-15 Building track record
Mizuho - Reiterated
Neutral → Neutral 2026-03-02 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-02 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-02-27 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-02-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
22/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →